About P&T JournalContacts:
Statement of Purpose
Guidelines for Authors
In this study, focus groups were conducted with pharmacy benefit decision-makers, to better understand the role of health-related quality-of-life information in the formulary management process.
Thomas Delate, MS, Frank R. Ernst, PharmD, and Stephen Joel Coons, PhD
Lawrence M. Prescott, PhD
Continuing Education Credit
The review explains the health and economic benefits of using combination drugs.
Albert Wertheimer, PhD and Alan Morrison, PhD
Matthew Grissinger, RPh, discusses the confusion with
concentrated insulin, problems caused by the national
fentanyl shortage, and a succinylcholine vial mix-up
Matthew Grissinger, RPh
Editor-in-Chief David B. Nash explains the
concept of “Graceful Degradation.”
David B. Nash, MD, MBA
A new semisynthetic antimicrobial to treat respiratory tract infections.
Thomas File, MD
The latest information about approvals, indication changes, industry updates, and news from the FDA.